Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

Mesoblast (MESO) Return on Sales: 2015-2023

Historic Return on Sales for Mesoblast (MESO) over the last 7 years, with Jun 2023 value amounting to -9.86%.

  • Mesoblast's Return on Sales fell 92.00% to -9.86% in Q2 2023 from the same period last year, while for Jun 2023 it was -9.86%, marking a year-over-year decrease of 92.00%. This contributed to the annual value of -5.94% for FY2025, which is 896.00% up from last year.
  • Latest data reveals that Mesoblast reported Return on Sales of -9.86% as of Q2 2023, which was down 1.64% from -9.70% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's Return on Sales ranged from a high of -2.42% in Q2 2020 and a low of -16.01% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was -9.83% (2022), whereas its average is -10.63%.
  • Per our database at Business Quant, Mesoblast's Return on Sales crashed by 1,347bps in 2021 and then soared by 689bps in 2022.
  • Over the past 5 years, Mesoblast's Return on Sales (Quarterly) stood at -4.22% in 2019, then tumbled by 131bps to -5.54% in 2020, then slumped by 421bps to -9.75% in 2021, then fell by 20bps to -9.94% in 2022, then slumped by 92bps to -9.86% in 2023.
  • Its Return on Sales stands at -9.86% for Q2 2023, versus -9.70% for Q1 2023 and -9.94% for Q4 2022.